The study aims to identify if Hydrus microstent implantation in patients with open angle glaucoma (OAG) at the time of cataract surgery improves quality of life for patients and explore what quality of life factors motivate patients.
Prospective, interventional single arm study of patient-reported outcomes (PRO) via GSS with pre and post ocular surface disease assessment in subjects undergoing bilateral phaco and Hydrus implantation; Study will also explore other QOL factors that may motivate patients to accept Hydrus via Glauc-QOL36 and customized questions.
Study Type
OBSERVATIONAL
Enrollment
38
Hydrus Microstent placed at the time of cataract surgery
Terri Smith
Fresno, California, United States
RECRUITINGChange in Glaucoma Symptom Score (GSS) Score
GSS is a cross-sectional study of symptoms, functional impairment, and vision-targeted health-related quality of life among persons with glaucoma, scored 0-100, with a higher score being more favorable (ie fewer adverse symptoms).
Time frame: 3 months
Number of Medication Reduction for Glaucoma
The number of glaucoma medications used before the intervention are compared to the number used after.
Time frame: 3 months
Ocular surface disease (OSD) assessment
The Oxford Grading System is used to grade the amount of corneal and conjunctival fluorescein staining, scored 0 (none) to V.
Time frame: 3 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.